Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 539
Filter
1.
J Trauma Acute Care Surg ; 92(2): 330-338, 2022 02 01.
Article in English | MEDLINE | ID: mdl-34789698

ABSTRACT

BACKGROUND: Trauma increases susceptibility to secondary bacterial infections. The events suppressing antimicrobial immunity are unclear. Polymorphonuclear neutrophils (PMNs) migrate toward bacteria using chemotaxis, trap them in extracellular neutrophil extracellular traps, and kill them using respiratory burst (RB). We hypothesized that plasma and wound fluids from trauma patients alter PMN function. METHODS: Volunteer PMNs were incubated in plasma or wound fluids from trauma patients (days 0 and 1, days 2 and 3), and their functions were compared with PMNs incubated in volunteer plasma. Chemotaxis was assessed in transwells. Luminometry assessed total and intracellular RB responses to receptor-dependent and independent stimulants. Neutrophil extracellular trap formation was assessed using elastase assays. The role of tissue necrosis in creating functionally suppressive systemic PMN environments was assessed using a novel pig model where PMNs were incubated in uninjured pig plasma or plasma from pigs undergoing intraperitoneal instillation of liver slurry. RESULTS: Both plasma and wound fluids from trauma patients markedly suppress total PMN RB. Intracellular RB is unchanged, implicating suppression of extracellular RB. Wound fluids are more suppressive than plasma. Biofluids suppressed RB maximally early after injury and their effects decayed with time. Chemotaxis and neutrophil extracellular trap formation were suppressed by biofluids similarly. Lastly, plasma from pigs undergoing abdominal liver slurry instillation suppressed PMN RB, paralleling suppression by human trauma biofluids. CONCLUSION: Trauma plasma and wound fluids suppress RB and other key PMNs antimicrobial functions. Circulating suppressive signals can be derived from injured or necrotic tissue at wound sites, suggesting a key mechanism by which tissue injuries can put the host at risk for infection.


Subject(s)
Neutrophils/immunology , Respiratory Burst/immunology , Wounds and Injuries/immunology , Animals , Chemotaxis , Exudates and Transudates/immunology , Humans , Plasma Volume/immunology , Swine
2.
Front Immunol ; 12: 780453, 2021.
Article in English | MEDLINE | ID: mdl-34925358

ABSTRACT

Background: Tuberculous pleural effusion (TPE) is one of the most common forms of extrapulmonary tuberculosis (Tb). Patients with TPE or malignant pleural effusions (MPE) frequently have a similar lymphocytic pleural fluid profile. Since the etiology of PE in various diseases is different, identifying the cellular components may provide diagnostic clues for understanding the pathogenesis. Objective: We determined the frequency of T helper (Th) subtypes in the PEs for differentiation of Tb and non-Tb patients. Methods: Thirty patients with TPE, 30 patients with MPE, 14 patients with empyema (EMP), and 14 patients with parapneumonic effusion (PPE) were enrolled between December 2018 and December 2019. Five-milliliter fresh PE in tubes containing heparin as an anticoagulant was obtained from patients. The frequencies of CD4+IL-9+, CD4+IL-22+, CD+IL-17+, and regulatory T-cells CD4+CD25+ FOXP3+ (Treg) were determined by flow cytometry. Results: Treg cells have a lower frequency in TPE patients [4.2 (0.362-17.24)] compared with non-TPE patients [26.3 (3.349-76.93, p < 0.0001)]. The frequency of CD4+IL-9+ cells was significantly lower in TPE patients [3.67 (0.87-47.83)] compared with non-TPE groups [13.05 (1.67-61.45), p < 0.0001]. On the contrary, there was no significant difference in the frequency of CD4+IL-17+ and CD4+IL-22+ cells between TPE and non-TPE patients (p = 0.906 and p = 0.2188). Receiver-operator curve (ROC) analysis demonstrated that CD4+CD25+FOXP3+ T cells [optimal cutoff value = 13.6 (%), sensitivity 90%, specificity 75.86%] could be considered as predictor for TPE. However, adenosine deaminase [cutoff value 27.5 (IU/l), sensitivity 90%, specificity 96.5%] levels had an even greater predictive capacity. Conclusion: ADA, Treg cells, and CD4+IL-9+ cells may differentiate TPE from non-TPE patients. However, these results need validation in an independent large cohort.


Subject(s)
Exudates and Transudates/cytology , Pleural Effusion/diagnosis , T-Lymphocyte Subsets/immunology , T-Lymphocytes, Helper-Inducer/immunology , Tuberculosis, Pleural/diagnosis , Diagnosis, Differential , Exudates and Transudates/immunology , Feasibility Studies , Female , Humans , Lymphocyte Count , Male , Middle Aged , Pleural Effusion/immunology , Pleural Effusion/pathology , Predictive Value of Tests , ROC Curve , T-Lymphocyte Subsets/metabolism , T-Lymphocytes, Helper-Inducer/metabolism , Tuberculosis, Pleural/immunology , Tuberculosis, Pleural/pathology
3.
Diagn Cytopathol ; 49(8): 948-958, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33973738

ABSTRACT

BACKGROUND: Serous effusions (SE) in leukemic patients can be due to infections, therapy, volume overload, lymphatic obstruction or malignancy having implications on treatment and mortality. The objective of the present study is to highlight the spectrum of cytomorphology, immunophenotype, and cytogenetics in leukemic serous effusions (LSE). MATERIALS: Present study is retrospective and descriptive. We reviewed all the SE, which were reported as suspicious or positive of leukemic infiltration from 2016 to 2019 for cytomorphological features. CSF and effusions involved by lymphomas were excluded. Cyto-diagnosis was compared with primary proven diagnosis (by ancillary techniques) and disconcordant cases were analyzed. RESULTS: Out of total 9723 effusions, only 0.4% (n = 40) showed leukemic involvement and included nine cases of AML, three of B-ALL, 13 T-ALL, 2 MPAL, 6 CML, 5CLL, one each of chronic myelomonocytic leukemia and AML with myelodysplasia. The most common site of involvement was the pleural cavity (n = 30), followed by the peritoneal cavity (n = 7) and the pericardial cavity (n = 3). T -ALL (41.9%) was the most common leukemia involving pleural fluid followed by AML (23.3%). CML (42.8%) was the most common leukemia involving the ascitic fluid followed by B-ALL (28.6%). Accurate diagnosis was given on cytomorphology in 72.5% (29/40) cases and 15.0% (6/40) were reported as non-Hodgkin lymphoma. CONCLUSION: Cytology is an effective tool available to make a diagnosis of LSE. Nuclear indentations in large atypical cells and cells with eosinophilic granular cytoplasm with sparse or abundant eosinophils in the background are an important clue in favor of leukemia over lymphoma.


Subject(s)
Cytogenetic Analysis , Exudates and Transudates , Immunophenotyping , Leukemia , Lymphoma , Adolescent , Adult , Aged , Aged, 80 and over , Ascitic Fluid/immunology , Ascitic Fluid/pathology , Child , Child, Preschool , Cytodiagnosis/methods , Cytological Techniques/methods , Diagnosis, Differential , Exudates and Transudates/cytology , Exudates and Transudates/immunology , Female , Flow Cytometry/methods , Humans , Infant , Leukemia/diagnosis , Leukemia/pathology , Lymphoma/diagnosis , Lymphoma/pathology , Lymphoma, Non-Hodgkin/diagnosis , Lymphoma, Non-Hodgkin/pathology , Male , Middle Aged , Pericardial Effusion/genetics , Pericardial Effusion/immunology , Pericardial Effusion/pathology , Pleural Effusion/genetics , Pleural Effusion/immunology , Pleural Effusion/pathology , Retrospective Studies
4.
Plast Reconstr Surg ; 147(2): 345-354, 2021 02 01.
Article in English | MEDLINE | ID: mdl-33565825

ABSTRACT

BACKGROUND: As the leading complication of abdominoplasty, seroma formation might represent an inflammatory process in response to surgical trauma. This prospective randomized trial investigated whether local administration of the antiinflammatory agent triamcinolone could prevent seroma accumulation. METHODS: Weekly and cumulative seroma volumes were compared between the study groups A, B, and C over a 4-week follow-up (group A, with drain, without triamcinolone; group B, without drain, without triamcinolone; group C, without drain, with triamcinolone). Aspirated seroma samples were analyzed by enzyme-linked immunosorbent assay for selective inflammatory mediators. RESULTS: Triamcinolone significantly reduced cumulative seroma volume (n = 60; mA 845 ± SDA 578 ml, mC 236 ± SDC 381 ml, p = 0.001). The most accentuated suppressive effect of triamcinolone was observed shortly after the treatment (week 1) (mA1 616 ± SDA1 457 ml, mB1 153 ± SDB1 161 ml, mC1 22 ± SDC1 44 ml, pA1/C1 < 0.001, pB1/C1 = 0.014). Local triamcinolone administration resulted in a differential concentration of interleukin-6 (IL-6) and matrix metalloproteinase-9 (MMP-9 (week 1) in seroma exudate as measured by enzyme-linked immunosorbent assay (mIL-6A1 1239 ± SDA1 59 pg/ml, mIL-6C1 848 ± SDC1 80 pg/ml, p < 0.001; mMMP-9A1 2343 ± SDA1 484 pg/ml, mMMP-9C1 376 ± SDC1 120 pg/ml, p = 0.001). CONCLUSIONS: Local administration of 80 mg of triamcinolone reduced postabdominoplasty seroma accumulation significantly. Under triamcinolone treatment, suppressed levels of IL-6 and MMP-9 in seroma fluid were observed. Notably, inflammatory marker suppression correlated clinically with a decrease in seroma accumulation. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.


Subject(s)
Abdominoplasty/adverse effects , Anti-Inflammatory Agents/administration & dosage , Drainage/methods , Seroma/therapy , Triamcinolone/administration & dosage , Adult , Combined Modality Therapy/methods , Enzyme-Linked Immunosorbent Assay , Exudates and Transudates/chemistry , Exudates and Transudates/diagnostic imaging , Exudates and Transudates/drug effects , Exudates and Transudates/immunology , Female , Follow-Up Studies , Humans , Interleukin-6/analysis , Interleukin-6/immunology , Male , Matrix Metalloproteinase 9/analysis , Matrix Metalloproteinase 9/immunology , Middle Aged , Postoperative Complications , Prospective Studies , Seroma/diagnosis , Seroma/etiology , Therapeutic Irrigation/methods , Treatment Outcome , Ultrasonography
5.
J Innate Immun ; 12(5): 373-386, 2020.
Article in English | MEDLINE | ID: mdl-32203966

ABSTRACT

Based on observations in vivo in guinea-pig and human airways, this review presents plasma exudation as non-sieved transmission of bulk plasma across an unperturbed mucosa that maintains its normal barrier functions. Several steps have led to the present understanding of plasma exudation as a non-injurious response to mucosal challenges. The implication of a swift appearance of all circulating multipotent protein systems (also including antimicrobial peptides that now are viewed as being exclusively produced by local cells) on challenged, but intact, mucosal surfaces cannot be trivial. Yet, involvement of early plasma exudation responses in innate mucosal immunology has dwelled below the radar. Admittedly, exploration of physiological plasma exudation mechanisms requires in vivo approaches beyond mouse studies. Plasma exudation also lacks the specificity that is a hallmark of biological revelations. These aspects separate plasma exudation from mainstream progress in immunology. The whole idea, presented here, thus competes with strong paradigms currently entertained in the accepted research front. The present focus on humoral innate immunity in vivo further deviates from most discussions, which concern cell-mediated innate defence. Indeed, plasma exudation has emerged as sole in vivo source of major mucosal defence proteins that now are viewed as local cell produce. In conclusion, this review highlights opportunities for complex actions and interactions provided by non-sieved plasma proteins/peptides on the surface of intact mucosal barriers in vivo.


Subject(s)
Immunity, Innate , Mucous Membrane/immunology , Animals , Blood Proteins/immunology , Blood Proteins/metabolism , Exudates and Transudates/immunology , Exudates and Transudates/metabolism , Humans , Mucous Membrane/metabolism , Plasma/immunology , Plasma/metabolism , Respiratory Tract Diseases/immunology , Respiratory Tract Diseases/pathology
6.
J Tissue Viability ; 29(1): 42-47, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31866230

ABSTRACT

BACKGROUND: The SIS Wound Matrix (SISWM) has been shown to improve healing of chronic ulcers over standard of care. In this study, we tested the hypothesis that chronic venous ulcers responsive to treatment with SISWM would more closely mimic an acute wound state as opposed to unresponsive ulcers. METHODS: Serum and wound exudate were collected at baseline and then weekly for up to 12 weeks from 12 patients receiving multiple applications of the SISWM. Levels of matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-9, and MMP-12), pro-inflammatory cytokines (IL-1ß, TNF-α, IL-8), and transforming growth factor beta (TGF-ß1) were evaluated. A variety of Th1/Th2 cytokines were also assayed, as were systemic anti-SIS and anti-α-gal antibody titers. RESULTS: Seven of the 12 patients eventually healed their wounds. Results showed significant decreases in MMP-1, MMP-2, MMP-3, MMP-9, TNF-α and IL-8, and significant increases in TGF-ß1 in wounds responding to treatment with the SISWM versus wounds that did not respond to treatment. None of the 12 patients formed a measurable serum antibody response to the SISWM. CONCLUSIONS: These data show that SISWM does not lead to immune system recognition or sensitization to the matrix and that wounds that went on to heal following treatment were characterized by a more acute wound state. The study confirms that the wound environment is important to healing and that turning a wound toward an acute biochemical state is key to the healing process.


Subject(s)
Leg Ulcer/therapy , Matrix Metalloproteinases/administration & dosage , Adolescent , Adult , Exudates and Transudates/immunology , Female , Humans , Leg Ulcer/blood , Male , Matrix Metalloproteinases/immunology , Treatment Outcome , Wound Healing , Young Adult
7.
J Clin Microbiol ; 58(1)2019 12 23.
Article in English | MEDLINE | ID: mdl-31619524

ABSTRACT

Pleural tuberculosis (PlTB), a common form of extrapulmonary TB, remains a challenge in the diagnosis among many causes of pleural effusion. We recently reported that the combinatorial analysis of interferon gamma (IFN-γ), IFN-γ-inducible protein 10 (IP-10), and adenosine deaminase (ADA) from the pleural microenvironment was useful to distinguish pleural effusion caused by TB (microbiologically confirmed or not) among other etiologies. In this cross-sectional cohort study, a set of inflammatory mediators was quantified in blood and pleural fluid (PF) from exudative pleural effusion cases, including PlTB (n = 27) and non-PlTB (nTB) (n = 25) patients. The levels of interleukin-2 (IL-2), IL-4, IL-6, IL-10, IL-17A, IFN-γ, tumor necrosis factor (TNF), IP-10, transforming growth factor ß1 (TGF-ß), and ADA were determined using cytometric bead assay, enzyme-linked immunosorbent assay (ELISA), or biochemical tests. IFN-γ, IP-10, TNF, TGF-ß, and ADA quantified in PF showed significantly higher concentrations in PlTB patients than in nTB patients. When blood and PF were compared, significantly higher concentrations of IL-6 and IL-10 in PF were identified in both groups. TGF-ß, solely, showed significantly increased levels in PF and blood from PlTB patients when both clinical specimens were compared to those from nTB patients. Principal-component analysis (PCA) revealed a T helper type 1 (Th1) pattern attributed mainly to higher levels of IP-10, IFN-γ, TGF-ß, and TNF in the pleural cavity, which was distinct between PlTB and nTB. In conclusion, our findings showed a predominantly cellular immune response in PF from TB cases, rather than other causes of exudative effusion commonly considered in the differential diagnosis of PlTB.


Subject(s)
Exudates and Transudates/immunology , Mycobacterium tuberculosis/immunology , Pleural Effusion/immunology , Th1 Cells/immunology , Tuberculosis, Pleural/immunology , Adult , Aged , Aged, 80 and over , Biomarkers , Comorbidity , Cytokines/metabolism , Female , Host-Pathogen Interactions/immunology , Humans , Inflammation Mediators/metabolism , Male , Middle Aged , Th1 Cells/metabolism , Tuberculosis, Pleural/diagnosis , Tuberculosis, Pleural/metabolism , Tuberculosis, Pleural/microbiology , Young Adult
8.
Front Immunol ; 10: 1858, 2019.
Article in English | MEDLINE | ID: mdl-31440247

ABSTRACT

Bullous pemphigoid (BP) is a cutaneous autoimmune disease, characterized by an inflammatory cascade leading to blister formation. Although macrophages were shown to participate in BP pathophysiology, their role in the blister formation process still needs to be investigated. We here addressed the influence of serum and blister fluid (BF) from patients with BP on the polarization status of macrophages with regards to the metalloproteinase-9 (MMP-9) expression. We demonstrated that several markers related to the alternatively activated macrophage phenotype (M2) including IL-10, TARC, arginase, TNFα, and IL-1RA were meaningfully increased in BF of patients with BP. We further showed that BF, but not serum from patients with BP, significantly induced the expression of CD163, CD206, and IL-10 in BP monocyte-derived macrophages (MDMs). Notably IL-10 was the only cytokine to be correlated to the reference clinical score, BP disease activity index (BPDAI), especially to the inflammatory BPDAI subscore evaluating urticarial and erythematous skin lesions (r = 0.57, p = 0.0004). We also found elevated levels of MMP-9 to M2-type macrophages ex vivo and highlighted the presence of CD163+ MMP-9+ macrophages histologically, at skin lesional site. Finally, we showed that methylprednisolone reduced MMP-9 levels in MDMs without modifying the other M2 markers. All together these results strongly support the presence of M2-phenotype macrophages with pro-inflammatory properties susceptible to favor blister formation in BP.


Subject(s)
Exudates and Transudates/immunology , Macrophage Activation/immunology , Macrophages/immunology , Matrix Metalloproteinase 9/immunology , Pemphigoid, Bullous/immunology , Blister/immunology , Humans
9.
Curr Opin Pulm Med ; 25(4): 384-390, 2019 07.
Article in English | MEDLINE | ID: mdl-30883447

ABSTRACT

PURPOSE OF REVIEW: The causes of exudative pleural effusions are diverse and frequently remain unclear despite exhaustive examinations. Recently recognized IgG4-related disease (IgG4-RD) is a fibroinflammatory disorder that can affect nearly any organ including the lungs. This review will focus on the involvement of IgG4 in exudative pleural effusion of unknown cause. RECENT FINDINGS: IgG4 is found to be involved in a proportion of patients with undiagnosed pleural effusions. Pleural involvement in IgG4-RD can be seen in isolation or association with other organ disease. Pleural thickening and/or effusion are common clinical features of IgG4-related pleural lesions, and this condition is histologically characterized by a lymphoplasmacytic infiltrate enriched in IgG4-positive plasma cells in the pleura. Although the pathogenesis of IgG4-RD is poorly understood, there is a growing body of evidence that indicates an antigen-driven process requiring T-cell and B-cell interaction in which autoantibodies, plasmablasts, follicular helper T cells and CD4+ cytotoxic T lymphocytes participate. SUMMARY: The possibility of IgG4-related pleural lesion should be considered in patients with pleural effusion of unexplained cause when lymphoplasmacytic infiltration is seen in a pleural biopsy specimen. This condition is responsive to systemic steroid therapy.


Subject(s)
Immunoglobulin G4-Related Disease , Pleura , Pleural Effusion , Biopsy/methods , Diagnosis, Differential , Exudates and Transudates/immunology , Humans , Immunoglobulin G4-Related Disease/complications , Immunoglobulin G4-Related Disease/physiopathology , Pleura/immunology , Pleura/pathology , Pleural Effusion/diagnosis , Pleural Effusion/etiology , Pleural Effusion/immunology
10.
J Allergy Clin Immunol ; 143(4): 1271-1286, 2019 04.
Article in English | MEDLINE | ID: mdl-30170125

ABSTRACT

This review discusses in vivo airway aspects of plasma exudation in relation to current views on epithelial permeability and epithelial regeneration in health and disease. Microvascular-epithelial exudation of bulk plasma proteins characteristically occurs in asthmatic patients, being especially pronounced in those with severe and exacerbating asthma. Healthy human and guinea pig airways challenged by noninjurious histamine-leukotriene-type autacoids also respond through prompt mucosal exudation of nonsieved plasma macromolecules. Contrary to current beliefs, epithelial permeability in the opposite direction (ie, absorption of inhaled molecules) has not been increased in patients with asthma and allergic rhinitis or in acutely exuding healthy airways. A slightly increased subepithelial hydrostatic pressure produces such unidirectional outward perviousness to macromolecules. Lack of increased absorption permeability in asthmatic patients can further be reconciled with occurrence of epithelial shedding, leaving small patches of denuded basement membrane. Counteracting escalating barrier breaks, plasma exudation promptly covers the denuded patches. Here it creates and sustains a biologically active barrier involving a neutrophil-rich, fibrin-fibronectin net. Furthermore, in the plasma-derived milieu, all epithelial cell types bordering the denuded patch dedifferentiate and migrate from all sides to cover the denuded basement membrane. However, this speedy epithelial regeneration can come at a cost. Guinea pig in vivo studies demonstrate that patches of epithelial denudation regeneration are exudation hot spots evoking asthma-like features, including recruitment/activation of granulocytes, proliferation of fibrocytes/smooth muscle cells, and basement membrane thickening. In conclusion, nonsieved plasma macromolecules can operate on the intact airway mucosa as potent components of first-line innate immunity responses. Exuded plasma also takes center stage in epithelial regeneration. When exaggerated, epithelial regeneration can contribute to the inception and development of asthma.


Subject(s)
Asthma/metabolism , Cell Membrane Permeability/physiology , Immunity, Innate/immunology , Plasma/metabolism , Respiratory Mucosa/metabolism , Animals , Asthma/immunology , Exudates and Transudates/immunology , Exudates and Transudates/metabolism , Humans , Plasma/immunology , Regeneration/physiology , Respiratory Mucosa/immunology
11.
BMC Pulm Med ; 17(1): 180, 2017 Dec 08.
Article in English | MEDLINE | ID: mdl-29216864

ABSTRACT

BACKGROUND: The ability of interleukins (ILs) to differentiate tuberculous pleural effusion from other types of effusion is controversial. The aim of our study was to summarize the evidence for its use of ruling out or in tuberculous pleural effusion. METHODS: Two investigators independently searched PubMed, EMBASE, Web of Knowledge, CNKI, WANFANG, and WEIPU databases to identify studies assessing diagnostic role of ILs for tuberculous pleural effusion published up to January, 2017. Study quality was assessed using Quality Assessment of Diagnostic Accuracy Studies-2. The pooled diagnostic sensitivity and specificity of ILs were calculated by using Review Manager 5.3. Area under the summary receiver operating characteristic curve (AUC) was used to summarize the overall diagnostic performance of individual markers. RESULTS: Thirty-eight studies met our inclusion criteria. Pooled sensitivity, specificity and AUC for chosen ILs were as follows: IL-2, 0.67,0.76 and 0.86; IL-6, 0.86, 0.84 and 0.90; IL-12, 0.78, 0.83 and 0.86; IL-12p40, 0.82,0.65 and 0.76; IL-18, 0.87, 0.92 and 0.95; IL-27, 0.93, 0.95 and 0.95; and IL-33, 0.84, 0.80 and 0.88. CONCLUSIONS: Some of these ILs may assist in diagnosing tuberculous pleural effusion, though no single IL is likely to show adequate sensitivity or specificity on its own. Further studies on a large scale with better study design should be performed to assess the diagnostic potential of ILs.


Subject(s)
Exudates and Transudates/immunology , Interleukins/immunology , Pleural Effusion/immunology , Tuberculosis, Pleural/immunology , Area Under Curve , Humans , Pleural Effusion/diagnosis , Pleural Effusion/etiology , Sensitivity and Specificity , Tuberculosis, Pleural/complications , Tuberculosis, Pleural/diagnosis
12.
Res Vet Sci ; 114: 294-296, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28605693

ABSTRACT

The effect of flunixin transdermal pour-on solution (Finadyne® Transdermal; MSD Animal Health) on prostaglandin E2 (PGE2) synthesis in bovine inflammatory exudate was evaluated in a tissue cage model of acute inflammation. Twelve calves were randomly allocated to two-treatment groups over two sequences. Three weeks prior to the first period, sterile hollow perforated polyethylene balls were surgically embedded in the subcutis at four distinct sites in each animal. On the first day of each period, an aseptic inflammation was induced by injecting 0.5mL of a 2% carrageenan solution into the lumen of each tissue cage. Treatment with either flunixin transdermal or negative control (NaCl) immediately followed. 0.5mL of exudate was collected prior to challenge, and at 2, 4, 8, 12, 24, 36 and 48h after challenge. Exudate PGE2 concentrations were analyzed using ultra-high pressure liquid chromatography coupled with tandem mass spectrometry method. Mean PGE2 concentrations were consistently lower in calves treated with flunixin transdermal than those measured in calves treated with negative control, indicating an inhibitory activity on cyclooxygenase. Inhibition was the highest at 8h after treatment, and differences with the negative control were significant at +8, 24, 36 and 48h. The flunixin transdermal formulation was effective in reducing PGE2 concentrations in bovine exudate following an induced inflammation. Its anti-inflammatory action started in the first hours after treatment and lasted up to 48h.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cattle Diseases/drug therapy , Clonixin/analogs & derivatives , Dinoprostone/biosynthesis , Inflammation/veterinary , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Cattle , Cattle Diseases/immunology , Clonixin/administration & dosage , Clonixin/therapeutic use , Exudates and Transudates/immunology , Inflammation/drug therapy , Inflammation/immunology , Random Allocation
13.
Int J Mol Sci ; 18(5)2017 May 13.
Article in English | MEDLINE | ID: mdl-28505080

ABSTRACT

Fingertip response to trauma represents a fascinating example of tissue regeneration. Regeneration derives from proliferative mesenchymal cells (blastema) that subsequently differentiate into soft and skeletal tissues. Clinically, conservative treatment of the amputated fingertip under occlusive dressing can shift the response to tissue loss from a wound repair process towards regeneration. When analyzing by Immunoassay the wound exudate from occlusive dressings, the concentrations of brain-derived neurotrophic factor (BDNF) and leukemia inhibitory factor (LIF) were higher in fingertip exudates than in burn wounds (used as controls for wound repair versus regeneration). Vascular endothelial growth factor A (VEGF-A) and platelet-derived growth factor (PDGF) were highly expressed in both samples in comparable levels. In our study, pro-inflammatory cytokines were relatively higher expressed in regenerative fingertips than in the burn wound exudates while chemokines were present in lower levels. Functional, vascular and mechanical properties of the regenerated fingertips were analyzed three months after trauma and the data were compared to the corresponding fingertip on the collateral uninjured side. While sensory recovery and morphology (pulp thickness and texture) were similar to uninjured sides, mechanical parameters (elasticity, vascularization) were increased in the regenerated fingertips. Further studies should be done to clarify the importance of inflammatory cells, immunity and growth factors in determining the outcome of the regenerative process and its influence on the clinical outcome.


Subject(s)
Burns/genetics , Cell Differentiation/genetics , Finger Injuries/genetics , Regeneration/genetics , Adult , Aged , Brain-Derived Neurotrophic Factor/genetics , Burns/physiopathology , Exudates and Transudates/immunology , Exudates and Transudates/metabolism , Exudates and Transudates/physiology , Finger Injuries/physiopathology , Humans , Leukemia Inhibitory Factor/genetics , Male , Mesenchymal Stem Cells/metabolism , Mesenchymal Stem Cells/physiology , Middle Aged , Occlusive Dressings , Platelet-Derived Growth Factor/genetics , Vascular Endothelial Growth Factor A/genetics , Wound Healing/genetics , Wound Healing/physiology
14.
Clin Respir J ; 11(3): 361-366, 2017 May.
Article in English | MEDLINE | ID: mdl-26148910

ABSTRACT

INTRODUCTION: The etiological diagnosis of pleural effusion is a difficult task because the diagnostic tools can only establish a definitive etiological diagnosis in at most 76% of cases. OBJECTIVES: To verify the diagnostic accuracy of the latex agglutination test (LAT) for the etiological diagnosis of pleural effusions caused by Streptococcus pneumoniae and Haemophilus influenzae type b. METHODS: After thoracocentesis, paired fresh samples of pleural fluid from 418 children and adolescents were included in this investigation. They were tested blindly and simultaneously through counterimmunoelectrophoresis (CIE) and LAT for both bacteria. Sensitivity, specificity, predictive values and likelihood ratios (LR) were calculated taking CIE as a reference standard. RESULTS: The sensitivity and specificity of LAT was 100% (95% confidence interval, 94.4%-100%) and 83.3% (95% confidence interval, 79.0%-87.0%), respectively, whereas the positive (calculated from Bayes' theorem) and negative predictive values were, respectively, lower than 1% and 100% (95% confidence interval, 98.8%-100%). Positive and negative LR were 6.0 (95% confidence interval, 4.7-7.6) and zero, respectively. CONCLUSIONS: Our results suggest that LAT is a useful tool for the etiological diagnosis of pleural effusion. It is a reliable, rapid, simple to perform and shows an excellent yield in our studied population, helping to prescribe appropriate antibiotics for this clinical condition.


Subject(s)
Counterimmunoelectrophoresis/methods , Exudates and Transudates/immunology , Latex Fixation Tests/methods , Pleural Effusion/diagnosis , Adolescent , Brazil/epidemiology , Child , Child, Preschool , Exudates and Transudates/microbiology , Female , Haemophilus influenzae type b/isolation & purification , Humans , Infant , Infant, Newborn , Male , Pleural Effusion/etiology , Pleural Effusion/microbiology , Pleural Effusion/virology , Predictive Value of Tests , Prospective Studies , Streptococcus pneumoniae/isolation & purification , Thoracentesis/methods
15.
Immunol Invest ; 46(2): 149-158, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27819528

ABSTRACT

Hidradenitis suppurativa (HS) is a chronic recurrent inflammatory disease of apocrine glands which affects 1-4% of young adults. The purpose of this study was to investigate inflammatory cytokines in effluent from HS lesions and to identify potential local drivers of inflammation in HS. Wound fluid specimens from HS patients (n = 8) and age-matched chronic wound patients (n = 8) were selected for analysis. The hidradenitis suppurativa score (HSS) was used to determine the extent of HS activity. Cytokine analysis was conducted using Meso Scale Discovery cytokine and proinflammatory panels. Interferon-gamma (IFN-γ) was significantly elevated in the HS effluent compared to chronic wounds (1418 ± 1501 pg/ml compared to 102.5 ± 138 pg/ml, p = 0.027). HS effluent also had significantly higher levels of tumor necrosis factor-ß (TNF-ß) (9.24 ± 7.22 pg/ml compared to 1.65 ± 2.14 pg/ml, p = 0.03). There was no significant difference in any other cytokines. There was no significant difference in demographics in the HS compared to chronic wound cohorts. Mean HSS in the HS cohort was 68.88 (SD ± 41.45). In this proof-of-concept pilot study, IFN-γ was significantly elevated in HS effluent. TNF-ß/LT-α levels were also elevated in HS, although the levels were more modest. Further studies should focus on molecular drivers of tissue injury in HS and the relationship between HS effluent cytokine profile and disease activity.


Subject(s)
Apocrine Glands/pathology , Exudates and Transudates/metabolism , Hidradenitis Suppurativa/immunology , Interferon-gamma/metabolism , Lymphotoxin-alpha/metabolism , Wounds and Injuries/metabolism , Adult , Cohort Studies , Disease Progression , Exudates and Transudates/immunology , Female , Humans , Male , Middle Aged , Pilot Projects , Up-Regulation
16.
Curr Opin Pulm Med ; 22(4): 367-77, 2016 07.
Article in English | MEDLINE | ID: mdl-27064428

ABSTRACT

PURPOSE OF REVIEW: This article summarizes current data regarding the accuracy of pleural fluid tests assisting the diagnosis of tuberculous pleuritis (TBP). RECENT FINDINGS: No pleural fluid test reliably rules-in TBP in settings with low TBP prevalence. Interferon-γ) alone or in combination with adenosine deaminase (ADA) is more reliable than ADA for this purpose in nonlow prevalences. ADA can reliably rule-out TBP in prevalences of less than 40% although in higher prevalences the product of interleukin-27 and ADA is the most accurate rule-out test. SUMMARY: The definite diagnosis of TBP requires the isolation of Mycobacterium tuberculosis from pleural fluid or biopsies. Because of the low sensitivity of pleural fluid cultures and the invasiveness of pleural biopsy techniques, the concept of a pleural fluid test that accurately establishes or excludes TBP diagnosis has been proposed. Numerous pleural fluid tests have been evaluated for this purpose with ADA being the most widely accepted one. During the last years, it has been demonstrated that the ability of ADA to rule-in or rule-out TBP is affected by the prevalence of TBP in the setting where the test is used. The complementary use of interferon-γ or interleukin-27 increases the ability of ADA to rule-in or rule-out the disease, respectively.


Subject(s)
Adenosine Deaminase/analysis , Exudates and Transudates/chemistry , Interferon-gamma/analysis , Interleukins/analysis , Mycobacterium tuberculosis/isolation & purification , Pleural Effusion , Pleurisy/diagnosis , Tuberculosis, Pleural/diagnosis , Biomarkers/analysis , Exudates and Transudates/enzymology , Exudates and Transudates/immunology , Exudates and Transudates/microbiology , Humans , Pleural Effusion/enzymology , Pleural Effusion/epidemiology , Pleural Effusion/immunology , Pleural Effusion/microbiology , Pleurisy/epidemiology , Pleurisy/immunology , Prevalence , Tuberculosis, Pleural/epidemiology , Tuberculosis, Pleural/microbiology
17.
Toxicon ; 118: 121-8, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27109323

ABSTRACT

Envenomation by snakes of the species Bothrops atrox induces local and systemic effects. Local effects include drastic tissue damage and a marked inflammatory response as a result of the synthesis and release of a variety of protein and lipid mediators. Toll-like receptor (TLR) signaling pathways can play an important role in this response, leading to synthesis of these inflammatory mediators. This study investigated the influence of TLR2 on the acute inflammatory response induced by Bothrops atrox venom. Wild-type C57BL/6 mice (WT) and TLR2 gene knockout mice (TLR2(-/-)) were injected with Bothrops atrox venom (BaV), and the following responses to the venom were assessed in peritoneal exudate: leukocyte accumulation; release of mediators, including CCL-2, IL-10, IL-1ß, IL-6 and LTB4; protein expression of COX-1 and COX-2; and quantification of their products PGE2 and TXA2. After injection with BaV, the TLR2(-/-) mice (TLR2(-/-)BaV) had higher levels of IL-6 and CCL-2 than WT animals kept under the same conditions (WTBaV), together with an accumulation of polymorphonuclear leukocytes (PMNs), inhibition of IL-1ß and LTB4 and reduced mononuclear leukocyte influx. However, no significant differences in COX-2 protein expression or PGE2, TXA2 and IL-10 production between the TLR2(-/-)BaV and WTBav animals were observed. Together, these results indicate that the signaling pathway activated by TLR2 acts by modulating the induced inflammatory response to BaV through the direct action of venom-associated molecular patterns (VAMPs) or indirectly by forming damage-associated molecular patterns (DAMPs) and that this may have important therapeutic implications.


Subject(s)
Bothrops , Disease Models, Animal , Leukocytes/drug effects , Signal Transduction/drug effects , Snake Bites/metabolism , Toll-Like Receptor 2/metabolism , Viper Venoms/toxicity , Animals , Brazil , Cytokines/blood , Exudates and Transudates/drug effects , Exudates and Transudates/immunology , Exudates and Transudates/metabolism , Inflammation Mediators/blood , Leukocyte Count , Leukocytes/immunology , Leukocytes/metabolism , Male , Mice, Inbred C57BL , Mice, Knockout , Snake Bites/blood , Snake Bites/immunology , Specific Pathogen-Free Organisms , Toll-Like Receptor 2/agonists , Toll-Like Receptor 2/genetics
18.
Chest ; 149(6): 1494-500, 2016 06.
Article in English | MEDLINE | ID: mdl-26836920

ABSTRACT

BACKGROUND: Malignant pleural effusion (MPE) is common. Existing literature on pleural fluid compositions is restricted to cross-sectional sampling with little information on longitudinal changes of fluid biochemistry and cytokines with disease progression. Indwelling pleural catheters provide the unique opportunity for repeated sampling and longitudinal evaluation of MPE, which may provide insight into tumor pathobiology. METHODS: We collected 638 MPE samples from 103 patients managed with indwelling pleural catheters over 95 days (median, range 0-735 days) and analyzed them for protein, pH, lactate dehydrogenase, and glucose levels. Peripheral blood was quantified for hematocrit, platelets, leukocytes, protein, and albumin. Cytokine levels (monocyte chemotactic protein [MCP]-1; vascular endothelial growth factor; interleukin-6, -8, and -10; tumor necrosis factor-α; and interferon-gamma) were determined in 298 samples from 35 patients with mesothelioma. Longitudinal changes of all parameters were analyzed using a linear mixed model. RESULTS: Significant decreases were observed over time in pleural fluid protein by 8 g/L per 100 days (SE, 1.32; P < .0001) and pH (0.04/100 days; SE, 0.02; P = .0203), accompanied by a nonsignificant rise in lactate dehydrogenase. The ratio of pleural fluid to serum protein decreased by 0.06/100 days (SE, 0.02; P = .04). MPEs from mesothelioma (n = 63) had lower pleural fluid glucose (P = .0104) at baseline and a faster rate of decline in glucose (P = .0423) when compared with non-mesothelioma effusions (n = 38). A progressive rise in mesothelioma pleural fluid concentration of [log] MCP-1 ([log] 0.37 pg/mL per 100 days; SE, 0.13; P = .0046), but not of other cytokines, was observed. CONCLUSIONS: MPE fluids become less exudative and more acidic over the disease course. The rise in MCP-1 levels suggests a pathobiological role in MPE.


Subject(s)
Cytokines/analysis , Exudates and Transudates , Lung Neoplasms , Mesothelioma , Pleural Effusion, Malignant , Aged , Aged, 80 and over , Australia , Blood Cell Count/methods , Chemokine CCL2/analysis , Exudates and Transudates/immunology , Exudates and Transudates/metabolism , Female , Humans , Longitudinal Studies , Lung Neoplasms/complications , Lung Neoplasms/pathology , Male , Mesothelioma/complications , Mesothelioma/pathology , Mesothelioma, Malignant , Middle Aged , Pleural Effusion, Malignant/diagnosis , Pleural Effusion, Malignant/etiology , Pleural Effusion, Malignant/metabolism , Tumor Necrosis Factor-alpha/analysis , Vascular Endothelial Growth Factor A/analysis
19.
Proc Biol Sci ; 283(1823)2016 01 27.
Article in English | MEDLINE | ID: mdl-26817769

ABSTRACT

Some group-living species exhibit social immunity, where the immune response of one individual can protect others in the group from infection. In burying beetles, this is part of parental care. Larvae feed on vertebrate carcasses which their parents smear with exudates that inhibit microbial growth. We have sequenced the transcriptome of the burying beetle Nicrophorus vespilloides and identified six genes that encode lysozymes-a type of antimicrobial enzyme that has previously been implicated in social immunity in burying beetles. When females start breeding and producing antimicrobial anal exudates, we found that the expression of one of these genes was increased by approximately 1000 times to become one of the most abundant transcripts in the transcriptome. Females varied considerably in the antimicrobial properties of their anal exudates, and this was strongly correlated with the expression of this lysozyme. We conclude that we have likely identified a gene encoding a key effector molecule in social immunity and that it was recruited during evolution from a function in personal immunity.


Subject(s)
Coleoptera/genetics , Coleoptera/immunology , Exudates and Transudates/immunology , Gene Expression Regulation/immunology , Animals , Coleoptera/metabolism , Exudates and Transudates/metabolism , Female , Male , Phylogeny , Social Behavior , Transcriptome
20.
J Oral Maxillofac Surg ; 73(6): 1189-98, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25850919

ABSTRACT

PURPOSE: Surgical-site infection (SSI) after cervical neck dissection (CND) for head and neck squamous cell carcinoma (HNSCC) increases morbidity and delays adjuvant treatment. This study assessed changes in cytokines levels in postsurgical drainage fluid after CND and examined their predictive value for the early diagnosis of SSI. PATIENTS AND METHODS: An observational prospective pilot study was conducted in 39 consecutively recruited patients with HNSCC undergoing CND who were treated at the authors' service within the past 2 years. Patients met the following inclusion criteria: no previous chemotherapy or radiotherapy, closed-suction drainage, 30-day follow-up, prophylactic treatment with amoxicillin plus clavulanic acid and dexamethasone, no chronic inflammatory disease, and no previous neck surgery. Drainage samples were collected at postoperative days +1 and +3. Sample size was estimated based on SSI incidence after HNSCC surgery (∼15%; α risk, 0.05; ß risk, 0.2; 2-sided test). Interleukin (IL)-1ß, IL-2, IL-6, IL-8, IL-10, and tumor necrosis factor-α (TNF-α) levels were measured. Patients were followed to detect SSI. Sensitivity, specificity, and prognostic values were calculated for each cytokine at days +1 and +3 to diagnose SSI. RESULTS: SSI was diagnosed in 6 of 39 patients. Bilateral CND, tracheostomy, surgery duration longer than 7 hours, HNSCC stage T3 or T4, and reconstruction with pedicled flaps versus microvascular flaps for advanced-stage tumors were considered risk factors for SSI. All cytokines except IL-10 showed statistical differences between patients with SSI and those without SSI. The best receiver operating characteristic curves yielded cutoff values at day +1 (TNF-α >14.5 pg/mL; sensitivity, 100%; specificity, 87.88%) and day +3 (IL-1ß >115 pg/mL; sensitivity, 83.33%; specificity, 78.79%). Also, IL-2 levels higher than 6.5 pg/mL at day +1 (sensitivity, 83.33%; specificity, 69.7%) and day +3 (sensitivity, 100%; specificity, 69.7%) and IL-6 levels higher than 3,300 pg/mL at day +3 (sensitivity, 100%; specificity, 60.61%) yielded adequate diagnostic profitability. CONCLUSION: The results of this study suggest that the assessment of cytokine levels in drainage fluid soon after CND could provide a novel method for the early detection of SSI.


Subject(s)
Carcinoma, Squamous Cell/surgery , Drainage , Exudates and Transudates/immunology , Interleukin-1beta/analysis , Mouth Neoplasms/surgery , Neck Dissection/methods , Surgical Wound Infection/diagnosis , Tumor Necrosis Factor-alpha/analysis , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Forecasting , Humans , Interleukin-2/analysis , Interleukin-6/analysis , Interleukin-8/analysis , Male , Middle Aged , Neoplasm Staging , Operative Time , Pilot Projects , Prospective Studies , Risk Factors , Sensitivity and Specificity , Surgical Flaps/surgery , Tracheostomy/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...